Home › Funds › Venrock Adviser, LLC › INM

Venrock Adviser, LLC position in INM

InMed Pharmaceuticals Inc · Health Care

Venrock Adviser, LLC reported holding 32,685 shares of INM (InMed Pharmaceuticals Inc) in its Q2 2026 13F filing — a position valued at US$51K, representing 0.00% of its reported portfolio and ranking #33 among its reported holdings. Venrock Adviser, LLC first reported this position in Q2 2026.

Latest position (Q2 2026)32.69K sh
Reported value held$50.66K
Portfolio Weight0.00%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Venrock Adviser, LLC's INM position evolved

Venrock Adviser, LLC first disclosed a stake in INM in Q2 2026 at 32,685 shares (US$51K).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 32.69K $50.66K New

About INM and 13F data

INM (InMed Pharmaceuticals Inc) is a Health Care company. 19 other funds we track also report a position in INM — the largest reported positions include Vivo Capital, LLC (US$1.2M), Squadron Capital Management LLC (US$504K), Ursa Fund Management, LLC (US$195K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INM

All INM fund holders →

FAQ

How long has Venrock Adviser, LLC held INM?

Venrock Adviser, LLC has disclosed INM holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Venrock Adviser, LLC's current position in INM?

As of Q2 2026, Venrock Adviser, LLC holds 32.69K shares of INM (InMed Pharmaceuticals Inc), valued at $50.66K, representing 0.00% of its reported portfolio and ranking #33.

Has Venrock Adviser, LLC been buying or selling INM?

In the latest 13F filing (Q2 2026), Venrock Adviser, LLC newly opened its position in INM.

Which other funds hold INM?

Other major institutional holders of INM include Vivo Capital, LLC, Squadron Capital Management LLC, Ursa Fund Management, LLC, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.